Panagos Constantinos's Form 4 filing
IQVIA Holdings Inc. (IQV) · filed Sep 21, 2023
- Accession no.
- 0001478242-23-000091
- Filed
- Sep 21, 2023
- Trade date
- Sep 19, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $5.70M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Panagos ConstantinosCIK 0001917705 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | Common Stock | SSaleDisposed | −19,898 | $208.69F1 | −$4,152,513.62 | 14,250 | Direct | |
| Sep 19, 2023 | Common Stock | MOption exerciseAcquired | +2,853 | $95.23 | +$271,691.19 | 17,103 | Direct | |
| Sep 19, 2023 | Common Stock | MOption exerciseAcquired | +7,681 | $131.82 | +$1,012,509.42 | 24,784 | Direct | |
| Sep 19, 2023 | Common Stock | MOption exerciseAcquired | +11,202 | $161.70 | +$1,811,363.4 | 35,986 | Direct | |
| Sep 19, 2023 | Common Stock | MOption exerciseAcquired | +4,450 | $183.82 | +$817,999 | 40,436 | Direct | |
| Sep 19, 2023 | Common Stock | SSaleDisposed | −7,419 | $208.63F2 | −$1,547,825.97 | 33,017 | Direct | |
| Sep 19, 2023 | Common Stock | DReturned to the companyDisposed | −18,767 | $208.56 | −$3,914,045.52 | 14,250 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | Common Stock | MOption exerciseDisposed | −2,853 | $0.00 | $0 | 0 | Direct | |
| Sep 19, 2023 | Common Stock | MOption exerciseDisposed | −7,681 | $0.00 | $0 | 0 | Direct | |
| Sep 19, 2023 | Common Stock | MOption exerciseDisposed | −11,202 | $0.00 | $0 | 0 | Direct | |
| Sep 19, 2023 | Common Stock | MOption exerciseDisposed | −4,450 | $0.00 | $0 | 2,225 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.78 to $210.33 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.71 to $210.12 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
President, Research & Development Solutions